RS63699B1 - Upotreba sulkardina za tretman atrijalne fibrilacije - Google Patents

Upotreba sulkardina za tretman atrijalne fibrilacije

Info

Publication number
RS63699B1
RS63699B1 RS20220986A RSP20220986A RS63699B1 RS 63699 B1 RS63699 B1 RS 63699B1 RS 20220986 A RS20220986 A RS 20220986A RS P20220986 A RSP20220986 A RS P20220986A RS 63699 B1 RS63699 B1 RS 63699B1
Authority
RS
Serbia
Prior art keywords
composition
use according
pharmaceutically acceptable
dose
sulcardine
Prior art date
Application number
RS20220986A
Other languages
English (en)
Serbian (sr)
Inventor
Gary T Elliot
Yiping Wang
Donglu Bai
Original Assignee
Huyabio International Llc
Shanghai Institute Of Materia Medica Chinese Academy Of Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huyabio International Llc, Shanghai Institute Of Materia Medica Chinese Academy Of Sciences filed Critical Huyabio International Llc
Publication of RS63699B1 publication Critical patent/RS63699B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
RS20220986A 2009-11-17 2010-11-16 Upotreba sulkardina za tretman atrijalne fibrilacije RS63699B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26192509P 2009-11-17 2009-11-17
EP17182709.0A EP3311810B1 (en) 2009-11-17 2010-11-16 Use of sulcardine for the treatment of atrial fibrillation

Publications (1)

Publication Number Publication Date
RS63699B1 true RS63699B1 (sr) 2022-11-30

Family

ID=44060290

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20220986A RS63699B1 (sr) 2009-11-17 2010-11-16 Upotreba sulkardina za tretman atrijalne fibrilacije

Country Status (10)

Country Link
US (1) US8541464B2 (https=)
EP (2) EP2501381B1 (https=)
JP (2) JP6116908B2 (https=)
CN (3) CN104324024A (https=)
DK (2) DK2501381T3 (https=)
ES (2) ES2644818T3 (https=)
HU (2) HUE034007T2 (https=)
PL (2) PL2501381T3 (https=)
RS (1) RS63699B1 (https=)
WO (1) WO2011062906A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2501381B1 (en) * 2009-11-17 2017-07-26 Huya Bioscience International LLC Treatment of atrial fibrillation
EP2501380B1 (en) * 2009-11-17 2016-01-27 Huya Bioscience International LLC Slow infusion of sulcardine and its salts
SG2013035662A (en) 2013-05-08 2014-12-30 Menicon Singapore Pte Ltd Systems and methods for printing on a contact lens
CN113453677A (zh) * 2018-12-13 2021-09-28 沪亚生物国际有限责任公司 用于治疗急性心房颤动的舒卡定施用
SG11202108160YA (en) * 2019-01-29 2021-08-30 Huya Bioscience International Llc Sulcardine salts
CN112516136B (zh) * 2019-09-17 2024-03-01 中国科学院上海药物研究所 硫酸舒欣啶在制备抗心衰产品中的应用
IL298907A (en) * 2020-06-12 2023-02-01 Huyabio Int Llc Administering sulcardin for the treatment of acute atrial fibrillation
CN114984004B (zh) * 2022-05-25 2023-09-12 扬州中宝药业股份有限公司 硫酸舒欣啶在制备抗脓毒症药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1172908C (zh) * 1999-12-10 2004-10-27 中国科学院上海药物研究所 N-取代苄基或苯基芳香磺酰胺化合物及其用途
CN1939298A (zh) * 2005-09-29 2007-04-04 中国科学院上海药物研究所 硫酸舒欣啶固体和靶向制剂及其制备方法
EP2501381B1 (en) * 2009-11-17 2017-07-26 Huya Bioscience International LLC Treatment of atrial fibrillation
EP2501380B1 (en) * 2009-11-17 2016-01-27 Huya Bioscience International LLC Slow infusion of sulcardine and its salts

Also Published As

Publication number Publication date
CN105362264A (zh) 2016-03-02
WO2011062906A9 (en) 2011-10-06
EP3311810A1 (en) 2018-04-25
JP6116908B2 (ja) 2017-04-19
ES2644818T3 (es) 2017-11-30
DK2501381T3 (da) 2017-11-06
WO2011062906A8 (en) 2012-02-09
JP2016028054A (ja) 2016-02-25
US8541464B2 (en) 2013-09-24
ES2929185T3 (es) 2022-11-25
CN104324024A (zh) 2015-02-04
EP2501381A2 (en) 2012-09-26
PL3311810T3 (pl) 2022-12-05
EP2501381A4 (en) 2013-06-12
CN102665714A (zh) 2012-09-12
US20120309810A1 (en) 2012-12-06
HUE034007T2 (en) 2018-01-29
PL2501381T3 (pl) 2018-02-28
DK3311810T3 (da) 2022-10-24
WO2011062906A2 (en) 2011-05-26
EP3311810B1 (en) 2022-07-27
HUE060876T2 (hu) 2023-04-28
EP2501381B1 (en) 2017-07-26
JP2013511473A (ja) 2013-04-04
HK1254495A1 (en) 2019-07-19

Similar Documents

Publication Publication Date Title
RS63699B1 (sr) Upotreba sulkardina za tretman atrijalne fibrilacije
JP6173391B2 (ja) サルカルディン及びその塩の緩速点滴
JP2021519764A (ja) 線維性疾患を処置する方法
JP2013511473A5 (https=)
JP2013511472A5 (https=)
CA2524034A1 (en) Uses of ion channel modulating compounds
CN113453677A (zh) 用于治疗急性心房颤动的舒卡定施用
JP2720348B2 (ja) 脳細胞機能障害改善剤
HK1254495B (en) Use of sulcardine for the treatment of atrial fibrillation
KR20230024347A (ko) 급성 심방 세동의 치료를 위한 설카르딘 투여
EP0303357B1 (en) 4-Amino-6,7-dimethoxy-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl)quinoline for (treatment of cardiac arrhythmias).
HK1176859A (en) Treatment of atrial fibrillation
HK1176859B (en) Treatment of atrial fibrillation
JP2006528155A (ja) 3,7−ジアザビシクロ[3.3.1]ノナン化合物の、ヒト男性患者の抗不整脈事象治療及び/又は予防のための使用
EA045624B1 (ru) Введение сулькардина для лечения острой фибрилляции предсердий
JPH01283224A (ja) 抗高血圧の組み合わせ調合物
HK1176858B (en) Slow infusion of sulcardine and its salts
JPH02202822A (ja) 肝細胞増殖促進剤